ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Roche Holding Ag

Roche Holding Ag (0QQ6)

229.20
0.00
(0.00%)
Closed January 05 10:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
229.20
Bid
0.00
Ask
0.00
Volume
651
0.00 Day's Range 0.00
229.20 52 Week Range 229.20
Market Cap
Previous Close
229.20
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,837
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
58.72B
Net Profit
11.5B

About Roche Holding Ag

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Basel, Che
Founded
-
Roche Holding Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QQ6. The last closing price for Roche was CHF229.20. Over the last year, Roche shares have traded in a share price range of CHF 229.20 to CHF 229.20.

Roche currently has 0 shares outstanding.

0QQ6 Latest News

Roche’s Phase IIb study of prasinezumab missed primary endpoint, but suggests possible benefit in early-stage Parkinson’s disease

Roche’s Phase IIb study of prasinezumab missed primary endpoint, but suggests possible benefit in early-stage Parkinson’s disease PADOVA study showed numerical delay in motor progression and...

Roche transforms mass spectrometry diagnostics with launch of cobas® Mass Spec solution

Roche transforms mass spectrometry diagnostics with launch of cobas® Mass Spec solution Roche launches its cobas® Mass Spec solution, bringing mass spectrometry to the routine clinical labClinical...

Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness

Roche’s Vabysmo prefilled syringe (PFS) approved in the EU for three retinal conditions that can cause blindness Vabysmo PFS is the first and only prefilled syringe containing a bispecific...

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities

Roche receives CE Mark for new and updated molecular cobas 6800/8800 systems, enhancing laboratory efficiency and testing capabilities The new cobas 6800/8800 systems 2.0 enhances throughput, run...

New and updated data for Roche's fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma

New and updated data for Roche's fixed-duration Columvi and Lunsumio at ASH 2024 reinforce their potential to improve outcomes for people with lymphoma Long-term data confirm fixed-duration...

Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash

Roche commences tender offer for all shares of Poseida Therapeutics, Inc. for $9.00 per share in cash, plus a non-tradeable contingent value right for up to $4.00 per share in cash Basel, 9...

Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma

Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma Exploratory long-term follow-up analysis of the phase III POLARIX...

FDA accepts supplemental Biologics License Application for Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma

FDA accepts supplemental Biologics License Application for Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma Application is based on data from the...

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies Acquisition supports Roche’s Pharma Strategy and...

Roche reports update on Phase III SKYSCRAPER-01 study results

Roche reports update on Phase III SKYSCRAPER-01 study results Basel, 26 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) reports an update on the phase III SKYSCRAPER-01 study, evaluating...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100229.2229.2229.2937229.2DE
400229.2229.2229.25535229.2DE
1200229.2229.2229.24837229.2DE
2600229.2229.2229.24462229.2DE
5200229.2229.2229.25234229.2DE
15600229.2229.2229.26091229.2DE
26000229.2229.2229.24937229.2DE

0QQ6 - Frequently Asked Questions (FAQ)

What is the current Roche share price?
The current share price of Roche is CHF 229.20
What is the 1 year trading range for Roche share price?
Roche has traded in the range of CHF 229.20 to CHF 229.20 during the past year
What is the reporting currency for Roche?
Roche reports financial results in CHF
What is the latest annual turnover for Roche?
The latest annual turnover of Roche is CHF 58.72B
What is the latest annual profit for Roche?
The latest annual profit of Roche is CHF 11.5B
What is the registered address of Roche?
The registered address for Roche is GRENZACHERSTRASSE 124, BASEL, 4070
What is the Roche website address?
The website address for Roche is www.roche.com
Which industry sector does Roche operate in?
Roche operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Viking61 Viking61 1 minute ago
Rick , do you have a kick starter on that whale horn??
FNMA
MartinLutherKing MartinLutherKing 1 minute ago
Will they get an FDA fast track status for terminally ill cancer patients
https://synapse.patsnap.com/blog/fda-approves-transcodes-phase-12-trial-of-ttx-mc138-for-advanced-solid-tumors
barnyarddog barnyarddog 1 minute ago
About us


GCT Semiconductor is a leading fabless designer and supplier of advanced 4G LTE semiconductor solutions. GCT’s market-proven LTE solutions enable fast and reliable LTE connectivity to wireless devices such as smartphones, tablets, hotspots, USB dongles,
GCT
tdbowieknife tdbowieknife 2 minutes ago
I just checked Sedar and still nothing filed. I know they could if they tried as there have been 6 other disclosure docs filed Today. Some of them PR's a few Material change.

.
TWOH
kid70 kid70 2 minutes ago
I wish JB would actually give you something new to report on.  You are reporting on old and false news.   Kevin is working for another company and Kevin has sold the building 
UBQU
Lime Time Lime Time 3 minutes ago
Very nice. Gonna be a good one VGTL
VGTL
ron_66271 ron_66271 3 minutes ago
Marty Only has Two Weeks to Complete His Tasks.

Too control the narrative.
You do the math?!

Remember that JPM and the FDIC Lost in DC Court.
DOCUMENTED!



Ron
JPM
trunkmonk trunkmonk 3 minutes ago
Light took a guess where Carney was by a pic he posted, CarneyClown is on Jekyll island, his clue was a pic of drift wood on the beach, it was as cryptic and lacking in background, its something only Carney could think we all have time to figure out 10,000 places on earth just to see where he is. wh
FNMA
Lifetime Lifetime 4 minutes ago
You know that is not based in reality. Shameful.
jour_trader jour_trader 4 minutes ago
There is one patent (434 patent) that Purdue claimed against Accord that I don't see a ruling on. This is against Elite too. 

4 of these patents have been filed against Abai and KVK-Tech. Another filed against Amneal and Kashiv. 

There are 2 patents where Elite stands a
ELTP
barnyarddog barnyarddog 4 minutes ago
GCTS - Semiconductor signs MOU with Samsung to accelerate the development of 4G/5G chipsets and modules

SAN JOSE, CA – August 13, 2024
https://www.gctsemi.com/samsung-pr-august-13-2024

July 23, 2024 GCT Semiconductor and Ligado Networks Announce Commercial Avai
GCT GCTS
gfp927z gfp927z 4 minutes ago
>>> Moody’s Acquires Numerated Growth Technologies, Expanding Lending Technology Solutions


Business Wire

November 21, 2024


https://finance.yahoo.com/news/moody-acquires-numerated-growth-technologies-130000091.html


NE
MCO
juicyjuice10002 juicyjuice10002 5 minutes ago
Let it trade on a real exchange so all the players sitting cn sideline can come and decide the price. There will be analysts from all over on this case. My invetment advisor claims the price will be over 90.
https://sinvestsllc.com/fannie-mae-fnma-price-target-90/
FNMA
3331 3331 5 minutes ago
Another GetSeriousOK gem!
Tuesday, 12/12/2023 7:42:35 PM
Post #324816

There's nothing so critically wrong with BIEL that it can't be fixed. This company isn't screwing shareholders the way ENDV is screwing shareholders, for example.
ENDV
KILLAZILLA KILLAZILLA 5 minutes ago
Hallelujah!!!!
MNMD
MartinLutherKing MartinLutherKing 6 minutes ago
Is NIH a scam like the fda
https://synapse.patsnap.com/article/transcode-therapeutics-receives-2m-nih-grant-for-lead-candidate-clinical-evaluation
jobynimble jobynimble 6 minutes ago
https://x.com/krtlbiotech/status/1876063562759868634?s=61&t=yVFUOJsDIX47DnFKN2pKtQ

“Attention $KRTL shareholders: Our website, krtlbiotech.com, will be going live soon, accompanied by a scheduled press release detailing its features and functions.”
KRTL
tredenwater2 tredenwater2 7 minutes ago
Roger that loud n clear!
MUX
newmedman newmedman 7 minutes ago
cdn.bsky.app/img/feed_thumbnail/plain/did:plc:mzvcmrbi3poceuzt66ujpw46/bafkreidxznbasw7r6ukdetmm4pa2sc3uvljsfcof272uebdt7dbjmtzm3a@jpeg
trader59 trader59 8 minutes ago
He stops in often enough to keep his moderator status and uses re-hashed previously debunked garbage from the fairy tale he and the others you call the "good guys" used to flip the stock for profit. That's it.
You've declared it to be over a few times only to return to another sliver of the
joyceschoice joyceschoice 8 minutes ago
Yes let's make this a Lehman political board to solve all of the problems that currently are at issue. Economic inequality and political pandering, free speech, women's right to health care, school shootings and gun control for the children women bear, mass shootings and gun control for the humans
LEHNQ
tdbowieknife tdbowieknife 9 minutes ago
Cause that is not what is happening... TWOH needs to PR the Change of control and file the docs and PR on Sedar. They screwed it up badly by filing that 8-k and not following Canadian disclosure at the same time.... Now they need to fix it. They for sure will NOT lift the halt until the disclosu
TWOH
Poo28 Poo28 9 minutes ago
LTI’s do loans—cashflow financing. No equity. No increase in OS since June 2023. Maybe your opinion is because your short selling pals are telling you what to say?

Stop making it up as you go along. False, false and false.?
DBMM

Your Recent History

Delayed Upgrade Clock